4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001753159-26-000012
Co-Chief Executive Officer sold 210,000 shares at an average $109.89 ($23,076,690)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Talasaz AmirAli · Co-Chief Executive Officer
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-20 | Sale : show line 1 in the form 10b5-1 | −200 | $100.95 | $20,190 | 2,096,304 | I |
| 2026-05-20 | Sale : show line 2 in the form 10b5-1 | −900 | $102.57 | $92,313 | 2,095,404 | I |
| 2026-05-20 | Sale : show line 3 in the form 10b5-1 | −1,366 | $103.82 | $141,815 | 2,094,038 | I |
| 2026-05-20 | Sale : show line 4 in the form 10b5-1 | −11,919 | $105.01 | $1,251,589 | 2,082,119 | I |
| 2026-05-20 | Sale : show line 5 in the form 10b5-1 | −1,200 | $105.88 | $127,050 | 2,080,919 | I |
| 2026-05-20 | Sale : show line 6 in the form 10b5-1 | −21,171 | $106.99 | $2,265,126 | 2,059,748 | I |
| 2026-05-20 | Sale : show line 7 in the form 10b5-1 | −33,069 | $108.11 | $3,574,961 | 2,026,679 | I |
| 2026-05-20 | Sale : show line 8 in the form 10b5-1 | −9,852 | $108.97 | $1,073,547 | 2,016,827 | I |
| Open-market sales · 210,000 sh · avg $109.89 · $23,076,690 | ||||||
Loading xslF345X06/wk-form4_1779483475.xml…